The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Open accessAbstract
BACKGROUND: Drugs that selectively inhibit serotonin reuptake are effective treatments for adults with mood and anxiety disorders, but limited data are available on the safety and efficacy of serotonin-reuptake inhibitors in children with anxiety disorders. METHODS: We studied 128 children who were 6 to 17 years of age; who met the criteria for social phobia, separation anxiety disorder, or generalized anxiety disorder; and who had received psychological treatment for three weeks without improvement. The children were randomly assigned to receive fluvoxamine (at a maximum of 300 mg per day) or placebo for eight weeks and were evaluated with rating scales designed to assess the degree of anxiety and impairment. RESULTS: Children in the fluvoxamine group had a mean (+/-SD) decrease of 9.7+/-6.9 points in symptoms of anxiety on the Pediatric Anxiety Rating Scale (range of possible scores, 0 to 25, with higher scores indicating greater anxiety), as compared with a decrease of 3.1+/-4.8 points among children in the placebo group (P<0.001). On the Clinical Global Impressions-Improvement scale, 48 of 63 children in the fluvoxamine group (76 percent) responded to the treatment, as indicated by a score of less than 4, as compared with 19 of 65 children in the placebo group (29 percent, P<0.001). Five children in the fluvoxamine group (8 percent) discontinued treatment because of adverse events, as compared with one child in the placebo group (2 percent). CONCLUSIONS: Fluvoxamine is an effective treatment for children and adolescents with social phobia, separation anxiety disorder, or generalized anxiety disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite its positive effects, the use of paroxetine may have caused as side-effects insomnia, decreased appetite, vomiting, withdrawal, agitation, emotional liability and four patients described suicide ideations without attempting to consummate.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, fluvoxamine is considered effective and well tolerated in the long-term treatment of anxiety disorders with children and adolescents [40].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the fluvoxamine condition drop-out was higher (n = 5) than the placebo group (n = 2) due to sideeffects.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, studies examining the efficacy of fluvoxamine and sertraline have reported a significant reduction in the severity of the anxiety symptoms after only 12 weeks [37,59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional research suggests that combining psychotherapy with pharmacotherapy yields better outcomes than either approach alone, as psychotherapy can teach valuable skills in managing fear-inducing social situations while pharmacotherapy alleviates symptoms facilitating greater participation in behavioral interventions [60,61].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [60]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another study found that 76% of participants treated with fluvoxamine were classified as 'much improved,' compared to 29% in the placebo group [59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The participants allocated to the fluvoxamine experimental group benefited from a significant decrease in anxiety symptoms compared to the participants allocated to the placebo group.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“The most prevalent observed side-effects were headache, abdominal discomfort, increased motor activity and difficulty falling asleep.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236
Self-citationPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Self-citationSHAFFER, D., FISHER, P., DULCAN, M. K., DAVIES, M., PIACENTINI, J., SCHWAB-STONE, M. E., LAHEY, B. B., BOURDON, K., JENSEN, P. S., BIRD, H. R., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199607000-00012 · Cited by 1,587
Self-citationUsers' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.21.2598 · Cited by 1,185
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 971
Research works printed but not linked: 3
- Greenhill LL, 1998, Psychopharmacol Bull, 34, 155
- Walkup J, Davies M. The Pediatric Anxiety Rating Scale (PARS): a reliability study. In: Scientific proceedings of the 46th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 19–24, 1999:NR78. abstract.
- Wagner KD, Birmaher B, Carlson G, et al. Multi-center trial of paroxetine and imipramine in the treatment of adolescent depression. In: Scientific proceedings of the 45th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Anaheim, Calif., October 27–November 1, 1998:S12D. abstract.
Cited by
Sorted by citations
Items 501–589 of 589
Pharmacologicalmanagement of childhood and adolescent anxiety disorders
Pelligrino, L., Pierce, C., & Walkup, J. T. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511994920.018 · Cited by 1
Self-citationAnxiolytika und Sedativa/Hypnotika
Reuter-Dang, S.-Y., Gerlach, M., Renner, T., & Warnke, A. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_7 · Cited by 1
Separation Anxiety and Panic Disorders in Children
Zagoloff, A. D., & Bernstein, G. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-57196-6_8 · Cited by 1
The effects of trauma on children: working to define roles for mental health professionals
Pine, D. (2003) · International Psychiatry · doi:10.1192/s1749367600006408
Self-citationThe Impact of Terrorism on Children and Adolescents
Abdu-Glass, E., Fremont, W. P., Pataki, C. S., & Beresin, E. V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54854-0.00005-9 · Cited by 1
Antidepressant drug treatment in Child and adolescent Psychiatry
Cardy, R. E., Dhaliwal, S. S., & Reddy, P. S. (2017) · Madridge Journal of Internal and Emergency Medicine · doi:10.18689/mjiem-1000106 · Cited by 2
Adolescent and Adult Mass Shooters
Mallett, C. A. (2019) · IGI Global eBooks · doi:10.4018/978-1-7998-0113-9.ch012 · Cited by 1
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00015-9 · Cited by 1
Muris, P. (2014) · Autism and child psychopathology series · doi:10.1007/978-3-319-06796-4_3 · Cited by 2
Intervention for autistic spectrum disorders
Filipek, P. A., Steinberg-Epstein, R., & Book, T. M. (2006) · Neurotherapeutics · doi:10.1007/bf03207050 · Cited by 1
Separation Anxiety Disorder in Children and Adolescents
Caporino, N. E., Wong, J. X., & Cannon, A. O. (2022) · Springer eBooks · doi:10.1007/978-3-031-14080-8_17 · Cited by 1
Anxiety Disorders in Youth: Separation Anxiety, Social Anxiety, and Generalized Anxiety Disorder
Walkup, J. T., Shechner, T., & Strawn, J. R. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_22 · Cited by 1
Self-citationBENIGN U-WAVE MISTAKEN FOR QTc PROLONGATION
Labellarte, M. J., Walkup, J. T., & Riddle, M. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046851.56865.82 · Cited by 1
Self-citationVenlafaxine Extended Release in Pediatric Anxiety and Depression
Miller, L., & Riddle, M. A. (2008) · Pediatric Health · doi:10.2217/17455111.2.3.279 · Cited by 1
Self-citationFluwoksamina - najdłużej stosowany lek z grupy selektywnych inhibitorów wychwytu serotoniny
Jaracz, J., & RYBAKOWSKI, J. K. (2006) · Cited by 1
Cheung, V., Ledesma, M., & Weitzman, C. C. (2018) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610021357-22 · Cited by 1
Nature, Assessment, and Treatment of Generalized Anxiety Disorder in Children
Hudson, J. L., Deveney, C., & Taylor, L. K. (2005) · Psychiatric Annals · doi:10.3928/00485713-20050901-04 · Cited by 1
Validation of the Italian version of the clinician affective reactivity index (CL-ARI)
Zaccaria, V., Maggi, S., Bof, A., Tofani, M., Galeoto, G., & Ardizzone, I. (2022) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2154837 · Cited by 1
Martin, A., & Bostic, J. Q. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.09.001 · Cited by 1
Purper‐Ouakil, D. (2007) · Elsevier eBooks · doi:10.1016/b978-2-294-70196-2.50007-5 · Cited by 1
Real World, Real Decisions: Treatment of Pediatric Anxiety Disorders
Brotman, M. A. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260662 · Cited by 1
Tone, E. B., Nawa, N. E., Nelson, E. E., Detloff, A. M., Fromm, S. J., Pine, D. S., & Ernst, M. (2011) · Developmental Neuropsychology · doi:10.1080/87565641.2010.549876 · Cited by 25
Self-citationPharmacotherapy for Adolescent Social Phobia
Ameringen, M. V., Turna, J., Patterson, B. A., & Lau, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-16703-9_14
Biologically Inspired Robot Arm Control Using Neural Oscillators
Yang, W., Young, N., & Jae, B. (2010) · InTech eBooks · doi:10.5772/7330
Childhood anxiety disorders: best treatment options and practice
Vidair, H. B., & Rynn, M. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.029
Bell, J., & Winkels, K. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced1891
Emotional disorders in children and adolescents
Harrington, R. (2004) · Medicine · doi:10.1383/medc.32.8.53.43168
Treatment of Pediatric Anxiety Disorders
Bernstein, G. A., & Victor, A. M. (2007) · Pediatric Health · doi:10.2217/17455111.1.2.191 · Cited by 1
Challenges in Using SSRIs in Young Anxious Children
Manassis, K. (2003) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.8.5.5.22903
En el niño preescolar y escolar
Rodrigo, M., & Hernández, R. (2004) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(04)71643-1
Rubio, B., & Alda, J. A. (2006) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(06)71252-x
New developments in pharmacotherapy of pediatric anxiety disorders
Garland, E. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.2.203
Escalas y cuestionarios pragmáticos en psicofarmacología pediátrica: ¿estamos haciendo lo correcto?
Coghill, D. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.001
Anxiety in the Primary Classroom: A Handbook for Elementary Educators
Ismailos, L. (2013) · Brock University Digital Repository (Brock University)
Understanding the causes of anxiety
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.015
Hazell, P. (2001) · Evidence-Based Mental Health · doi:10.1136/ebmh.4.4.116
Special Considerations in Treating Anxiety Disorders in Adolescents
Manassis, K., & Wilansky-Traynor, P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6458-7_11
Pharmacologic Approaches to Medication-Resistant Anxiety in Children and Adolescents
Larson, J. J., dosReis, S., Matthys, M., & Riddle, M. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7784-7_24
Self-citationPsicofarmacología en niños, niñas y adolescentes: una aproximación a la terapéutica
Campo, A., Camacho, G. Á., & Trillos, E. (2002) · Medunab · doi:10.29375/01237047.276
Psychopharmacology in Palliative Care and Oncology: Childhood and Adolescence
Forgey, M. J., & Bursch, B. (2014) · Springer eBooks · doi:10.1007/978-3-642-40134-3_18
Childhood Anxiety Disorders and Obsessive-Compulsive Disorder
Victor, A. M., Zagoloff, A. D., & Bernstein, G. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_21
DeVane, L., Carolina, S., Findling, R. L., & Masi, G. (2001)
Chapter 4. Combined CBT and Psychopharmacology
Singh, S., Lewis, L. R., Rabinovitch, A. E., Caraballo, A. A., D, M. A. M., & Rynn, M. A. (2012) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370955.es04
Antonuccio, D. O., & WASLICK, B. D. (2009)
Martin‐Guehl, C. (2007) · Elsevier eBooks · doi:10.1016/b978-2-294-70196-2.50015-4
Stapleton, E. J. (2019) · Digital Commons - DU (University of Denver)
Ryan, J. L., Fox, J. K., Lowe, S. R., & Warner, C. M. (2019) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.33.4.331
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50020-6
Terapia a largo plazo del trastorno de ansiedad generalizada
Rouillon, F. (2004) · European psychiatry (Ed Española) · doi:10.1017/s1134066500004483
School Shootings, Locked-Down Campuses, and Fear
Mallett, C. A. (2021) · Advances in educational marketing, administration, and leadership book series · doi:10.4018/978-1-7998-5200-1.ch002
Antidepressant usage by South African children and adolescents: A drug utilisation review
Rooyen, V., & Jacobus, C. (2013)
Fluvoxamine for anxiety disorders in younger patients?
&NA; (2001) · Inpharma Weekly · doi:10.2165/00128413-200112860-00022
Pae, C., & Patkar, A. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50056-1
Adolescent and Adult Mass Shooters
Mallett, C. A. (2021) · IGI Global eBooks · doi:10.4018/978-1-7998-8544-3.ch064
(2007) · Elsevier eBooks · doi:10.1016/b978-008045073-5/50011-3
Soutullo, C. A. (2021) · Springer eBooks · doi:10.1007/978-3-319-91280-6_403
10 Anxiety and Mood Disorders in an Emergency Context
(2017) · CRC Press eBooks · doi:10.1201/9781315271149-14
Sterling, L., & Wood, J. J. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1698-3_460
Pharmacologic Treatment of Pediatric Anxiety Disorders
Strawn, J. R., Dobson, E. T., Ramesh, A. B., Berger, S. A., & Rynn, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813004-9.00017-7
Sterling, L., & Wood, J. J. (2021) · Springer eBooks · doi:10.1007/978-3-319-91280-6_460
(2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.3.366
Mychailyszyn, M. P., Kendall, P. C., Domingues, J. C., & Treadwell, K. R. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375000-6.00322-0
Bell, J., & Winkels, K. (2014) · Encyclopedia of Special Education · doi:10.1002/9781118660584.ese2180
Jummani, R. R., & Shatkin, J. P. (2019) · Autism and child psychopathology series · doi:10.1007/978-3-030-21683-2_11
Conceptual Framework for Prescribing Psychotropic Medications
(2021) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610025478-2
Velasco, D. M. P., & Ospina‐Pinillos, L. (2022) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2022.03.005
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.002.0003
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.002.0006
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.002.0007
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.002.0002
Pharmacological Treatment of Anxiety Disorders in Children and Adolescents
Nibras, S. A., Truong, A. L., & Williams, L. L. (2022) · Springer eBooks · doi:10.1007/978-3-031-14080-8_23
Anxiety disorders in children and adolescents
Muris, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99613-6.00012-0
Anxiety Disorder in Youth: Separation Anxiety, Social Anxiety, and Generalized Anxiety Disorders
Walkup, J. T., Shechner, T., & Strawn, J. R. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_22-1
Self-citationTaurines, R., & Gerlach, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_5
Anxiolytika und Sedativa/Hypnotika
Fekete, S., Renner, T. J., & Gerlach, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65267-1_7
Advances in Pediatric Pharmacology, Therapeutics, and Toxicology
Paul, I. M., & Berlin, C. M. (2003) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00059-2
Heightened facial muscle reactivity in preadolescent girls with pathological anxiety
Cruz, J. R., Cochran, A. L., McFarlin, D. R., Williams, L. E., & Kalin, N. H. (2024) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.2006
“This approach is similar to large ‐ scale treatment trials of youth anxiety (Walkup et al., 2001, 2008), and we believe girls with this clinical phenotype are reflective of girls with pathological anxiety in the community and clinic.”
ResultConceptual Framework for Prescribing Psychotropic Medications
(2024) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610027663-ch2
Quality Ratings for Psychotherapies and Efficacy Data for Medications
(2024) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610027663-appd
The Relations Among Anxiety, Movie‐Watching, and in‐Scanner Motion
Kirk, P. A., Qamar, P., Zugman, A., Abend, R., Frank, S., Ringlein, G., Jett, L., DeLap, G. A. L., Harrewijn, A., Pine, D. S., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70163
Self-citationInnovative treatment approaches for paediatric obsessive-compulsive disorder
Marazziti, D., Gurrieri, R., Gambini, M., Russomanno, G., Palagini, L., & Mucci, F. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2591073
Treatment of anxiety: current status and controversial issues
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.024
Additional file 1 of Accounting for center-level effects in multicenter randomized controlled trials
Islam, S., & Bangdiwala, S. I. (2024) · Figshare · doi:10.6084/m9.figshare.26735643
The development and clinical impact of social anxiety disorder in children and adolescents
Puliafico, A. C., Detweiler, M. F., Comer, J. S., Crum, K. I., & Albano, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14146-1.00013-9
Anxiety in Underserved Populations: Identification, Assessment, and Treatment in Primary Care
Bitterman, M., Parkhurst, J. T., & Spencer, A. E. (2026) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610028493-ch14
Cassidy, M., Gloe, L. M., Biggs, B. K., Geske, J. R., & Whiteside, S. P. H. (2026) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2026.2673936
Selective Serotonin Reuptake Inhibitors (SSRIs)
Carle, K. J. (2026) · Springer eBooks · doi:10.1007/978-981-95-7244-1_2
(2026) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610029223-ch10
Serotonin-selektive Antidepressiva(SSRI, DSA)
Laux, G., Eckert, A., Müller, W. E. G., Breyer-Pfaff, U., Kasper, S. F., Riedel, M. J., Müller, N., Möller, H., Hiemke, C., Schoechlin, C., et al. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_4
Metadata
- Authors
- Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., Klee, B., McCracken, J., Bergman, L., Piacentini, J., March, J., Compton, S., Robinson, J., O'Hara, T., Baker, S., Vitiello, B., Ritz, L., & Roper, M.
- Affiliations
- New York State Psychiatric Institute (US)
- University of California, Los Angeles (US)
- Duke University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-04-26
- Volume
- 344
- Issue
- 17
- Pages
- 1279-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330595721
- Cited by
- 588
- References
- 42
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 18 · 2016: 17 · 2015: 19 · 2014: 20 · 2013: 23 · 2012: 23
- FWCI
- 73.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brown University
- Johns Hopkins University
- York University
- National Institutes of Health (n01mh060005-010, n01mh060016-007, n01mh070010-001)
- University of Illinois at Urbana-Champaign
- National Institute of Mental Health (N01 MH 70010, N01 MH60005, N01MH60016)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- fluvoxamine, selective serotonin reuptake inhibitors, childhood anxiety disorders, social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, children and adolescents, drug safety and efficacy, adverse events
- MeSH terms
- Adolescent, Anxiety Disorders, Anxiety, Separation, Child, Female, Humans, Male, Phobic Disorders, Psychotherapy, Anti-Anxiety Agents, Fluvoxamine, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
